Back to search
Lichen Planopilaris
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lichen Planopilaris trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Lichen Planopilaris trials you may qualify forThis study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Lichen planopilaris (LPP) is a primary lymphocytic cicatricial alopecia characterized by progressive, permanent hair loss and scalp symptoms such as pruritus an…
Rationale Lichen planopilaris (LPP) is a prevalent form of cicatricial alopecia, predominantly affecting women and causing irreversible hair loss. Hydroxychloro…
Lichen planus (LP) is a common immune-mediated skin disease with a prevalence of 1-2% in the general population. It can present with a broad spectrum of clinica…
This study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adults with lichen planopilaris (LPP) or ce…